Colchicine for Recurrent Pericarditis (CORP): A Randomized Trial

Recurrence is the most common complication of pericarditis, affecting 10% to 50% of patients. To evaluate the efficacy and safety of colchicine for the secondary prevention of recurrent pericarditis. Prospective, randomized, double-blind, placebo-controlled multicenter trial. (ClinicalTrials.gov reg...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of internal medicine 2011-10, Vol.155 (7), p.409-414
Hauptverfasser:	IMAZIO, Massimo, BRUCATO, Antonio, CEMIN, Roberto, FERRUA, Stefania, BELLI, Riccardo, MAESTRONI, Silvia, TRINCHERO, Rita, SPODICK, David H, ADLER, Yehuda
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Biological and medical sciences Cardiology. Vascular system Cardiovascular disease Clinical trials Colchicine - adverse effects Colchicine - therapeutic use Disease prevention Diseases of the pericardium Double-Blind Method Drug therapy Female General aspects Heart Humans Male Medical sciences Middle Aged Pericarditis - drug therapy Pericarditis - prevention & control Prospective Studies Secondary Prevention
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!